IONIS PHARMACEUTICALS INC - Common Stock (IONS)
CUSIP: 462222100
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 162,643,196
- Total 13F shares
- 113,771,923
- Share change
- -1,343,300
- Total reported value
- $5,722,698,300
- Put/Call ratio
- 120%
- Price per share
- $50.30
- Number of holders
- 308
- Value change
- -$67,824,507
- Number of buys
- 120
- Number of sells
- 151
Quarterly Holders Quick Answers
What is CUSIP 462222100?
CUSIP 462222100 identifies IONS - IONIS PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462222100:
Top shareholders of IONS - IONIS PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
18,653,203
|
$945,717,000 | — | 30 Sep 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
7%
|
11,439,851
|
$580,000,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7%
|
11,416,359
|
$578,810,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
9,943,951
|
$504,158,000 | — | 30 Sep 2017 | |
| BB BIOTECH AG |
13F
|
Company |
4.8%
|
7,861,934
|
$398,600,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
7,003,491
|
$355,077,000 | — | 30 Sep 2017 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.3%
|
6,968,149
|
$353,285,000 | — | 30 Sep 2017 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
2.8%
|
4,542,100
|
$230,285,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
2,941,821
|
$149,153,000 | — | 30 Sep 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
1.7%
|
2,708,407
|
$137,316,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,686,857
|
$85,524,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.87%
|
1,415,090
|
$71,745,000 | — | 30 Sep 2017 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.86%
|
1,398,465
|
$70,902,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.82%
|
1,341,733
|
$68,022,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.71%
|
1,154,048
|
$58,510,000 | — | 30 Sep 2017 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.7%
|
1,144,526
|
$58,027,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.69%
|
1,123,900
|
$56,982,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
1,049,631
|
$53,216,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0.61%
|
988,126
|
$50,098,000 | — | 30 Sep 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.6%
|
982,344
|
$49,805,000 | — | 30 Sep 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.57%
|
926,968
|
$46,997,000 | — | 30 Sep 2017 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.48%
|
776,949
|
$39,391,000 | — | 30 Sep 2017 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
705,407
|
$35,764,000 | — | 30 Sep 2017 | |
| DOWLING & YAHNKE LLC |
13F
|
Company |
0.42%
|
675,891
|
$34,268,000 | — | 30 Sep 2017 | |
| Fiera Capital Corp |
13F
|
Company |
0.39%
|
630,312
|
$31,957,000 | — | 30 Sep 2017 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.38%
|
612,952
|
$31,090,000 | — | 30 Sep 2017 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.37%
|
604,455
|
$30,646,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
591,378
|
$29,983,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
539,446
|
$27,349,000 | — | 30 Sep 2017 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.28%
|
450,000
|
$22,815,000 | — | 30 Sep 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.26%
|
424,910
|
$21,543,000 | — | 30 Sep 2017 | |
| Sicart Associates LLC |
13F
|
Company |
0.24%
|
389,022
|
$19,724,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.24%
|
387,492
|
$19,646,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
381,734
|
$19,354,000 | — | 30 Sep 2017 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.23%
|
368,980
|
$18,707,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.21%
|
338,205
|
$17,147,000 | — | 30 Sep 2017 | |
| Motley Fool Wealth Management, LLC |
13F
|
Company |
0.2%
|
332,007
|
$16,833,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.19%
|
314,664
|
$15,953,000 | — | 30 Sep 2017 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.18%
|
289,608
|
$14,683,000 | — | 30 Sep 2017 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.17%
|
281,068
|
$14,250,000 | — | 30 Sep 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.17%
|
270,194
|
$13,698,836 | — | 30 Sep 2017 | |
| Bellevue Group AG |
13F
|
Company |
0.16%
|
265,706
|
$13,469,000 | — | 30 Sep 2017 | |
| Motley Fool Asset Management LLC |
13F
|
Company |
0.16%
|
259,000
|
$13,131,000 | — | 30 Sep 2017 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.16%
|
257,705
|
$13,066,000 | — | 30 Sep 2017 | |
| ARK Investment Management LLC |
13F
|
Company |
0.15%
|
247,463
|
$12,546,000 | — | 30 Sep 2017 | |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
|
Company |
0.15%
|
240,503
|
$12,194,000 | — | 30 Sep 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.14%
|
222,900
|
$11,301,000 | — | 30 Sep 2017 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
207,300
|
$10,510,000 | — | 30 Sep 2017 | |
| AVIVA PLC |
13F
|
Company |
0.13%
|
206,784
|
$10,484,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
204,022
|
$10,347,000 | — | 30 Sep 2017 |
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2017
As of 31 Dec 2017,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,771,923 shares.
The largest 10 holders included
FMR LLC, Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BB BIOTECH AG, BlackRock Inc., BAILLIE GIFFORD & CO, WADDELL & REED FINANCIAL INC, STATE STREET CORP, and OppenheimerFunds, Inc..
This page lists
308
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
295
Q4 2017 holders
308
Holder diff
13
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.